List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17 studies with search of: Open Studies | "Rosacea"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Open Label Pilot Study of Apremilast in Treatment of Rosacea
Conditions: Erythematotelangiectatic Rosacea;   Papulopustular Rosacea
Intervention: Drug: Apremilast
2 Recruiting Atralin Gel for the Treatment of Rosacea
Condition: Rosacea
Interventions: Drug: vehicle gel;   Drug: Atralin gel
3 Not yet recruiting Rifaximin Treatment of Papulopustular Rosacea
Condition: Rosacea
Interventions: Drug: Rifaximin (XIFAXAN);   Drug: Placebo
4 Unknown † Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Condition: Rosacea
Interventions: Drug: Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel;   Drug: placebo
5 Recruiting Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation
Condition: Rosacea
Interventions: Drug: Topical aminocaproic acid (ACA) mixed with Vanicream;   Drug: Vehicle cream
6 Recruiting Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
Condition: Rosacea
Intervention: Drug: Topical Minocycline Foam FXFM244
7 Not yet recruiting Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
Condition: Papulopustular Rosacea
Interventions: Drug: Azelaic Acid;   Drug: Vehicle Foam
8 Recruiting Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Condition: Rosacea
Interventions: Drug: Doxycycline;   Other: Placebo
9 Recruiting A Study of DER 45-EV Gel to Treat Rosacea
Condition: Rosacea
Interventions: Drug: DER 45 EV;   Drug: Vehicle
10 Recruiting A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Condition: Rosacea
Interventions: Drug: Metronidazole Topical Gel 1%;   Drug: Metronidazole Topical Gel 1% (Metrogel);   Drug: Placebo
11 Recruiting Phase 3 Papulopustular Rosacea Study
Condition: Papulopustular Rosacea
Interventions: Drug: CD5024;   Drug: Azelaic acid 15% Gel
12 Recruiting CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Condition: Papulopustular Rosacea
Interventions: Drug: CD5024;   Drug: Metronidazole 0.75% cream
13 Recruiting Phase 3 Papulopustular Rosacea Study
Condition: Papulopustular Rosacea (PPR)
Interventions: Drug: CD5024;   Drug: Azelaic acid 15% Gel
14 Recruiting Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
Conditions: Rosacea;   Erythema
Interventions: Drug: AGN-199201 Formulation A and B;   Drug: AGN-199201 Formulation B and C;   Drug: AGN-199201 Formulation C and A;   Drug: AGN-199201 Formulatio A and AGN-199201 Vehicle;   Drug: AGN-199201 Formulation B and AGN-199201 Vehicle;   Drug: AGN-199201 Formulation C and AGN-199201 Vehicle;   Drug: AGN-199201 Formulation A;   Drug: AGN-199201 Formulation B;   Drug: AGN-199201 Formulation C;   Drug: AGN-199201 Vehicle
15 Recruiting Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Condition: Rosacea
Interventions: Drug: oral doxycycline and topical metronidazole;   Drug: oral doxycycline;   Drug: placebo
16 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
17 Recruiting Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
Condition: Rosacea
Intervention: Procedure: Pulse Dye Laser/YAG laser

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services